ChiCTR2500097299 版本V1.0 版本创建时间2025/02/17 14:38:34 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR2500097299 

最近更新日期:

Date of Last Refreshed on:

2025-02-17 14:38:19 

注册时间:

Date of Registration:

2025-02-17 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

血小板生成素受体激动剂治疗原发免疫性血小板减少症的临床综合评价研究

Public title:

Clinical comprehensive evaluation of thrombopoietin receptor agonists in the treatment of primary immune thrombocytopenia

注册题目简写:

English Acronym:

研究课题的正式科学名称:

血小板生成素受体激动剂治疗原发免疫性血小板减少症的临床综合评价研究

Scientific title:

Clinical comprehensive evaluation of thrombopoietin receptor agonists in the treatment of primary immune thrombocytopenia

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

程芳 

研究负责人:

张玉 

Applicant:

Fang Cheng 

Study leader:

Yu Zhang 

申请注册联系人电话:

Applicant telephone:

+86 13554280387

研究负责人电话:

Study leader's
telephone:

+86 27 85726685

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

chengfang321@163.com

研究负责人电子邮件:

Study leader's E-mail:

whxhzy@163.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

湖北省武汉市江汉区解放大道1277号

研究负责人通讯地址:

湖北省武汉市江汉区解放大道1277号

Applicant address:

1277 Jiefang Avenue, Jianghan District, Wuhan City, Hubei Province

Study leader's address:

NO.1277 Jiefang Avenue, Wuhan, Hubei Province

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

华中科技大学同济医学院附属协和医院

Applicant's institution:

Huazhong University of Science and Technology Tongji Medical College Affiliated Union Hospital

研究负责人所在单位:

华中科技大学同济医学院附属协和医院

Affiliation of the Leader:

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

[2025]伦审字(0125)号

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

华中科技大学同济医学院附属协和医院医学伦理委员会

Name of the ethic committee:

Ethics Committee of Union Hospital of Tongji Medical College Huazhong University of Science and Technology

伦理委员会批准日期:

Date of approved by ethic committee:

2025-02-10 00:00:00

伦理委员会联系人:

褚圆圆

Contact Name of the ethic committee:

Chu Yuanyuan

伦理委员会联系地址:

湖北省武汉市江汉区解放大道1277号

Contact Address of the ethic committee:

NO.1277 Jiefang Avenue, Wuhan, Hubei Province

伦理委员会联系人电话:

Contact phone of the ethic committee:

+86 27 85726375

伦理委员会联系人邮箱:

Contact email of the ethic committee:

994877373@qq.com

研究实施负责(组长)单位:

华中科技大学同济医学院附属协和医院

Primary sponsor:

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

研究实施负责(组长)单位地址:

湖北省武汉市江汉区解放大道1277号

Primary sponsor's address:

NO.1277 Jiefang Avenue, Wuhan, Hubei Province

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

湖北

市(区县):

Country:

China

Province:

Hubei

City:

单位(医院):

华中科技大学同济医学院附属协和医院

具体地址:

湖北省武汉市江汉区解放大道1277号

Institution
hospital:

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Address:

NO.1277 Jiefang Avenue, Wuhan, Hubei Province

经费或物资来源:

科技基础资源调查专项

Source(s) of funding:

Clinical Comprehensive Evaluation of Hospital Management Institute of National Health Commission

研究疾病:

原发性免疫性血小板减少症  

Target disease:

Primary immune thrombocytopenia

研究疾病代码:

Target disease code:

研究类型:

观察性研究

Study type:

Observational study

研究所处阶段:

其它 

Study phase:

N/A

研究设计:

队列研究 

Study design:

Cohort study 

研究目的:

本研究收集多中心ITP患者治疗安全性和有效性数据,从安全,有效,经济,适宜等角度系统分析TPO-RA在ITP治疗中的应用现状和前景,为临床医生提供更为科学合理的用药指导,并为ITP患者选择更有效的治疗方案提供实证依据  

Objectives of Study:

This study collected data on the safety and effectiveness of treatment for multi center ITP patients, and systematically analyzed the current application status and prospects of TPO-RA in ITP treatment from the perspectives of safety, effectiveness, economy, and suitability. It provides more scientific and reasonable medication guidance for clinical doctors and empirical evidence for ITP patients to choose more effective treatment plans

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

1.≥18岁;
2.确诊为ITP;
3.回顾性队列:2022.1.1-2024.3.1各中心确诊ITP并使用TPO-RA治疗;前瞻性队列:2025.3.1-2026.12.31各中心确诊ITP并使用TPO-RA治疗;
4.既往至少1种ITP药物(含激素)或脾切除治疗无效(PLT<30x109/L)或复发;
5.能完整收集与本研究目的相关信息的患者;

Inclusion criteria

1. >= 18 years old; 2. Diagnosed with ITP; 3. At least one previous ITP medication (including steroids) or splenectomy treatment was ineffective (PLT<30x109/L) or recurred; 4. Patients who are able to collect complete information related to the purpose of this study;

排除标准:

1.无;

Exclusion criteria:

1.None;

研究实施时间:

Study execute time:

From 2025-03-01 00:00:00 To 2027-03-01 00:00:00  

征募观察对象时间:

Recruiting time:

From 2025-03-01 00:00:00 To 2026-12-31 00:00:00

干预措施:

Interventions:

组别:

海曲泊帕组

样本量:

600

Group:

Herombopag group

Sample size:

干预措施:

干预措施代码:

Intervention:

None

Intervention code:

组别:

其他TPO-RA组

样本量:

600

Group:

Other TPO-RA group

Sample size:

干预措施:

干预措施代码:

Intervention:

None

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

湖北 

市(区县):

 

Country:

China

Province:

Hubei

City:

单位(医院):

华中科技大学同济医学院附属协和医院 

单位级别:

三甲 

Institution
hospital:

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

陕西 

市(区县):

 

Country:

China

Province:

Shaanxi

City:

单位(医院):

西安国际医学中心医院 

单位级别:

三级 

Institution
hospital:

Xi'an International Medical Center Hospital

Level of the institution:

Tertiary

国家:

中国

省(直辖市):

湖南 

市(区县):

 

Country:

China

Province:

Hunan

City:

单位(医院):

湘潭市中心医院 

单位级别:

三甲 

Institution
hospital:

Xiangtan Central Hospital

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

湖南 

市(区县):

 

Country:

China

Province:

Hunan

City:

单位(医院):

南华大学附属第一医院 

单位级别:

三甲 

Institution
hospital:

The First Affiliated Hospital of University of South China

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

上海 

市(区县):

 

Country:

China

Province:

Shanghai

City:

单位(医院):

上海交通大学医学院附属瑞金医院 

单位级别:

三甲 

Institution
hospital:

Ruijin Hospital, Shanghai Jiao Tong University School of Medicine

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

江苏 

市(区县):

 

Country:

China

Province:

Jiangsu

City:

单位(医院):

徐州医科大学附属医院 

单位级别:

三甲 

Institution
hospital:

The Affiliated Hospital of Xuzhou Medical University

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

重庆 

市(区县):

 

Country:

China

Province:

Chongqing

City:

单位(医院):

重庆医科大学附属第二医院 

单位级别:

三甲 

Institution
hospital:

The 2nd Affiliated Hospital of Chongqing Medical University

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

上海 

市(区县):

 

Country:

China

Province:

Shanghai

City:

单位(医院):

海军军医大学第一附属医院 

单位级别:

三甲 

Institution
hospital:

ShangHai ChangHai Hospital

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

四川 

市(区县):

 

Country:

China

Province:

Sichuan

City:

单位(医院):

四川省人民医院 

单位级别:

三甲 

Institution
hospital:

Sichuan Provincial People's Hospital

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

湖北 

市(区县):

 

Country:

China

Province:

Hubei

City:

单位(医院):

武汉市中心医院 

单位级别:

三甲 

Institution
hospital:

The Central Hospital of Wuhan

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

天津 

市(区县):

 

Country:

China

Province:

Tianjing

City:

单位(医院):

中国医学科学院血液病医院(中国医学科学院血液学研究所) 

单位级别:

三甲 

Institution
hospital:

Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College.

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

湖南 

市(区县):

 

Country:

China

Province:

Hunan

City:

单位(医院):

湖南省人民医院 

单位级别:

三甲 

Institution
hospital:

Hunan Provincial People's Hospital

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

河北 

市(区县):

 

Country:

China

Province:

Hebei

City:

单位(医院):

河北医科大学第一医院 

单位级别:

三甲 

Institution
hospital:

the first hospital of hebei medical university

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

广东 

市(区县):

 

Country:

China

Province:

Guangdong

City:

单位(医院):

中山大学附属第一医院 

单位级别:

三甲 

Institution
hospital:

The First Affiliated Hospital,Sun Yat-sen University

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

浙江 

市(区县):

 

Country:

China

Province:

Zhejiang

City:

单位(医院):

浙江大学医学院附属第二医院 

单位级别:

三甲 

Institution
hospital:

The second affiliated hospital of Zhejiang University school of medicine

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

湖南 

市(区县):

 

Country:

China

Province:

Hunan

City:

单位(医院):

长沙市中心医院 

单位级别:

三甲 

Institution
hospital:

Changsha Central Hospital

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

云南 

市(区县):

 

Country:

China

Province:

Yunnan

City:

单位(医院):

昆明医科大学第一附属医院 

单位级别:

三甲 

Institution
hospital:

First Affiliated Hospital of Kunming Medical University

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

江苏 

市(区县):

 

Country:

China

Province:

Jiangsu

City:

单位(医院):

常州市第一人民医院 

单位级别:

三甲 

Institution
hospital:

the First People's Hospital of Changzhou

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

广西 

市(区县):

 

Country:

China

Province:

Guangxi

City:

单位(医院):

右江民族医学院附属医院 

单位级别:

三甲 

Institution
hospital:

Affiliated Hospital of Youjiang Medical University for Nationalities

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

内蒙古 

市(区县):

 

Country:

China

Province:

Inner Mongolia

City:

单位(医院):

内蒙古自治区人民医院 

单位级别:

三甲 

Institution
hospital:

Inner Mongolia People's hospital

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

湖南 

市(区县):

 

Country:

China

Province:

Hunan

City:

单位(医院):

中南大学湘雅三医院 

单位级别:

三甲 

Institution
hospital:

The Third Xiangya Hospital Central South University

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

广东 

市(区县):

 

Country:

China

Province:

Guangdong

City:

单位(医院):

南方医科大学南方医院 

单位级别:

三甲 

Institution
hospital:

Southern Medical University Southern Hospital

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

宁夏 

市(区县):

 

Country:

China

Province:

Ningxia

City:

单位(医院):

宁夏回族自治区人民医院 

单位级别:

三甲 

Institution
hospital:

People's Hospital of Ningxia Hui Autonomous Region

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

江西 

市(区县):

 

Country:

China

Province:

Jiangxi

City:

单位(医院):

南昌大学第一附属医院 

单位级别:

三甲 

Institution
hospital:

The first affiliated hostipal of nanchang university

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

陕西 

市(区县):

 

Country:

China

Province:

Shaanxi

City:

单位(医院):

西安高新医院 

单位级别:

三甲 

Institution
hospital:

Xi 'an GaoXin Hospital

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

浙江 

市(区县):

 

Country:

China

Province:

Zhejiang

City:

单位(医院):

金华市中心医院 

单位级别:

三甲 

Institution
hospital:

JIN HUA MUNICIPALS CENTRAL HOSPITAL

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

上海 

市(区县):

 

Country:

China

Province:

Shanghai

City:

单位(医院):

上海市第十人民医院 

单位级别:

三甲 

Institution
hospital:

SHANGHAI TENTH PEOPLES HOSPITAL

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

山西 

市(区县):

 

Country:

China

Province:

Shanxi

City:

单位(医院):

山西医科大学第一医院 

单位级别:

三甲 

Institution
hospital:

The first hospital of Shanxi Medical University

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

山西 

市(区县):

 

Country:

China

Province:

Shanxi

City:

单位(医院):

山西省人民医院 

单位级别:

三甲 

Institution
hospital:

Shanxi Provincial People's Hospital

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

湖南 

市(区县):

 

Country:

China

Province:

Hunan

City:

单位(医院):

郴州市第一人民医院 

单位级别:

三甲 

Institution
hospital:

Chenzhou No.1 People’S Hospital

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

河北 

市(区县):

 

Country:

China

Province:

Hebei

City:

单位(医院):

河北医科大学第二医院 

单位级别:

三甲 

Institution
hospital:

The Second Hospital of Hebei Medical University

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

浙江 

市(区县):

 

Country:

China

Province:

Zhejiang

City:

单位(医院):

宁波大学附属第一医院 

单位级别:

三甲 

Institution
hospital:

Ningbo First Hospital

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

广西 

市(区县):

 

Country:

China

Province:

Guangxi

City:

单位(医院):

广西医科大学第二附属医院 

单位级别:

三甲 

Institution
hospital:

The Second Affiliated Hospital of Guangxi Medical University

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

北京 

市(区县):

 

Country:

China

Province:

Beijing

City:

单位(医院):

北京大学国际医院 

单位级别:

三级 

Institution
hospital:

Peking University International Hospital

Level of the institution:

Tertiary

国家:

中国

省(直辖市):

安徽 

市(区县):

 

Country:

China

Province:

Anhui

City:

单位(医院):

安徽省第二人民医院 

单位级别:

三甲 

Institution
hospital:

Anhui No.2 Provincial People‘s Hospital

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

天津 

市(区县):

 

Country:

China

Province:

Tianjing

City:

单位(医院):

天津医科大学总医院 

单位级别:

三甲 

Institution
hospital:

Tianjin Medical University General Hospital

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

河北 

市(区县):

 

Country:

China

Province:

Hebei

City:

单位(医院):

河北省沧州中西医结合医院 

单位级别:

三甲 

Institution
hospital:

Hebei Province Cangzhou Hospital of integrated Traditional Chinese and Western Medicine,Cangzhou,Hebei,China

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

甘肃 

市(区县):

 

Country:

China

Province:

Gansu

City:

单位(医院):

兰州大学第二医院 

单位级别:

三甲 

Institution
hospital:

Lanzhou University Second Hospital

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

江西 

市(区县):

 

Country:

China

Province:

Jiangxi

City:

单位(医院):

赣南医科大学第一附属医院 

单位级别:

三甲 

Institution
hospital:

First Affiliated Hospital of Gannan Medical University

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

江苏 

市(区县):

 

Country:

China

Province:

Jiangsu

City:

单位(医院):

南京鼓楼医院 

单位级别:

三甲 

Institution
hospital:

Drum Tower Hospital

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

湖北 

市(区县):

 

Country:

China

Province:

Hubei

City:

单位(医院):

华中科技大学同济医学院附属协和医院 

单位级别:

三甲 

Institution
hospital:

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

血小板计数

指标类型:

主要指标

Outcome:

Platelet counts

Type:

Primary indicator

测量时间点:

治疗后1周、2周、4周、8周、12周、16周、24周

测量方法:

血常规检查

Measure time point of outcome:

1 week, 2 weeks, 4 weeks, 8 weeks, 12 weeks, 16 weeks, 24 weeks after treatment

Measure method:

Blood routine examination

指标中文名:

达到早期反应、初步反应患者比例

指标类型:

次要指标

Outcome:

The proportion of patients with early response and initial response was achieved

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

治疗 8 周达到完全反应的患者比例

指标类型:

主要指标

Outcome:

Proportion of patients who achieved a complete response after 8 weeks of treatment

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

组织:

Sample Name:

N/A

Tissue:

人体标本去向

其它  

说明

Fate of sample:

0thers  

Note:

征募研究对象情况:

Recruiting status:

尚未开始

Not yet recruiting

年龄范围:

Participant age:

最小 Min age 18 years
最大 Max age years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

Randomization Procedure (please state who generates the random number sequence and by what method):

None

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

不公开/Private

盲法:

Blinding:

None

是否共享原始数据:

IPD sharing

否No

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

None

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

采用电子采集与管理系统(EDC)进行数据采集与管理

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

Using Electronic Data Collection and Management System (EDC) for data collection and management

数据与安全监察委员会:

Data and Safety Monitoring Committee:

无/No

注册人:

Name of Registration:

 2025-02-17 14:38:19